Lorianne Masuoka K. 4
4 · NEKTAR THERAPEUTICS · Filed Feb 10, 2011
Insider Transaction Report
Form 4
Lorianne Masuoka K.
SVP & Chief Medical Officer
Transactions
- Award
Stock Option
2011-02-08$10.69/sh+75,000$801,750→ 75,000 totalExercise: $10.69Exp: 2019-02-08→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]The shares subject to this stock option shall vest on a monthly pro-rata basis over a period of four (4) years from the grant date (February 8, 2011).